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1. Introduction
  According to the World Health Organisation (WHO), 
tuberculosis (TB) treatment default defined as interrupting 
treatment for at least two consecutive months[1], remains 
a major threat to TB control. Individuals who default from 
treatment can undermine efforts to control TB because such 
persons have an increased risk of clinical deterioration and 
complications, TB recurrence, relapse, treatment failures, 
and mortality[2,3]. Moreover, they may remain infectious; 
develop drug-resistant TB, and continue to be a source 
of transmission of TB in the community[4]. Of particular 
importance in Nigeria, default/sub-optimal adherence, and 
treatment failure may increase the risk of acquired drug-
resistant TB[4]. Of all previously treated TB cases registered 
in 2010, in Nigeria, 14.3% of them had multi drug-resistant 
TB[5]. 
  Nigeria ranks tenth among the 22 high-burden TB 
countries, with an estimated prevalence rate of 161 per 
100 000 population in 2012[6]. Although treatment success 
rates among new TB cases reached 85% in 2011[6], default 
rates may be as high as 30% in some settings[7]. Little 
is known about the predictors of treatment default in 
Nigeria[7,8]. Knowledge of the determinants of TB treatment 
default and mortality is critical for informing health policy 
solutions needed to improve the outcomes of TB care 
and contain the spread of the disease. Studies in other 
settings have identified several determinants for treatment 
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defaults and 151 (91.5%) of deaths occurred during the intensive phase of treatment. Risk of 
default increased with increasing age (adjusted odds ratio (aOR) 1.2; 95% confidence interval (CI) 
1.1-1.9), smear-negative TB case (aOR 2.3; CI 1.5-3.6), extrapulmonary TB case (aOR 2.7; CI 1.3-
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highest in extrapulmonary TB (aOR 3.0; CI 1.4-6.1) and smear-negative TB cases (aOR 2.4; CI 
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default, including at the individual (male sex, older age, 
rural residence, human immunodeficiency virus (HIV) co-
infection, low socio-economic status, homelessness), and 
health system levels (poor health care accessibility, attitudes 
of health care workers)[9-18]. However, only few studies have 
evaluated the determinants of TB-related mortality in sub-
Saharan Africa[18-20], and none in Nigeria. Since these factors 
can vary between settings and health systems, there is a 
need for site-specific research in order to develop targeted 
interventions.
  A previous study suggested that a shorter TB treatment 
regimen can substantially decrease default rates[21]. In 2010 
the WHO recommended a change in its treatment guidelines 
for TB from an 8-month anti-TB regimen 2RHZE/6EH 
(consisting of 2 months of rifampicin (R), isoniazid (H), 
pyrazinamide (Z) and ethambutol (E), followed by 6 months of 
ethambutol and isoniazid) to a 6-month regimen containing 
6 months of rifampicin (2RHZE/4RH)[22]. The Nigerian 
National TB Control Programme (NTP) adopted the current 
WHO guideline in January 2012[23]. Since these changes were 
adopted, it is unclear if the shorter treatment regimen lowers 
the risk of default or death during treatment. Therefore, there 
is a need to re-assess the determinants of treatment default 
and mortality among TB patients. Also, in the last five years, 
the use of antiretroviral therapy (ART) and cotrimoxazole 
preventive therapy (CPT) have been scaled-up among HIV-
infected TB patients through TB/HIV collaborative activities 
in high-burden countries[6]. The contribution of these factors 
to default or death during TB treatment is not known.
  The aim of this study was to describe the epidemiological 
characteristics of TB patients who defaulted or died during 
treatment. Specific objectives were to describe among adults 
(age 曒15 years) TB patients in Nigeria in 2011 and 2012: (1) 
the number and proportion of TB patients who defaulted, and 
died during TB treatment; (2) the rate of treatment default 
and death stratified by age, gender, residence, TB regimen 
received, residence, treatment category, HIV status and HIV 
treatment; and (3) the independent predictors of default, and 
death during TB treatment.
2. Materials and methods
2.1.  Study area and population
  The study was conducted in Ebonyi State, one of the 36 
states of Nigeria, located in the southeastern part of the 
country. The state has a human population of more than 2.5 
million people and 80% of them reside in the rural area[24]. 
The NTP follows the directly observed treatment, short 
course (DOTS) strategy and uses recognised international 
standards for the diagnosis and treatment of patients with 
TB. DOTS coverage in the state has reached 100%; however, 
its case detection rate remained around 40%[25]. The study 
sites included one rural secondary care (not-for-profit/
mission) private hospital and the only tertiary (public) 
hospital in Ebonyi State. The study sites were selected due 
to high TB notification rates and to allow for public-private 
mix comparison. Together they accounted for 50% of total TB 
notification in the state in 2009 and they serve an estimated 
1.5 million people in the state[26]. 
2.2. Study design
  This was a retrospective cohort study using a routinely 
collected data from the national surveillance system to 
analyse treatment default and death among registered adult 
patients who received TB treatment in one tertiary (public) 
and one secondary (private) health facility in Ebonyi State, 
Nigeria, between 1 January 2011 and 31 December 2012. The 
outcomes followed standard WHO definitions[1]. Treatment 
default was defined as the interruption of treatment for 2 
consecutive months, whilst death was defined as death for 
any reason during treatment[1]. 
2.3. Ethical approval
  This study was approved by the Ethics and Research 
Advisory Committee of the National Tuberculosis Control 
Programme, Ministry of Health, Ebonyi State, Nigeria.
2.4. Treatment regimen
  All new TB patients diagnosed before 2012 received 
an 8-month anti-tuberculosis regimen consisting of 
2RHZE/6EH[22]. In line with the recent WHO guideline, 
from 1st January 2012, the six-month regimen containing 
6 months of rifampicin: 2RHZE/4RH was started[22-23]. 
Previously treated TB patients had a 3-month intensive 
phase treatment with the addition of streptomycin to RHZE 
in the first two months[22,23]. The treatment given is observed 
using the community-DOTS approach where a family 
member (DOTS supporter) and/or a volunteer community 
health worker living in the patient’s community observe 
the patient intake of their drugs. All HIV-infected TB 
patients are given trimethoprim/sulfamethoxazole (CPT) to 
prevent other opportunistic infections. HIV treatment follows 
national and WHO guidelines with antiretroviral therapy 
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administered between two weeks and two months of starting 
TB treatment[22,23]. 
2.5. Data analyses
  Data from the 2011 and 2012 TB registers from the study 
sites were double-entered, checked, and analyzed using 
Epi Info 3.4.1 (CDC, Atlanta, GA USA). Data were analysed 
by frequencies and percentages for demographic, clinical 
characteristics and treatment outcomes. The main outcome 
variables, classified as dichotomous, were treatment default 
(Yes versus No), and death (Yes versus No). Explanatory 
variables were gender, age, residence, patient classification 
(new versus retreatment), treatment regimen (2RHZE/6EH 
versus 2RHZE/4RH), facility (public versus private), HIV 
status, ART use and CPT use. Univariate analyses (Chi-
square and Fisher’s exact tests) were used to determine 
significant associations between each of the outcome 
variables and the explanatory variables. We performed a 
stratified analysis to determine the occurrence of interaction 
and confounding between each outcome variable (default, 
and death) and the explanatory variables. Multivariable 
logistic regression models were then constructed, including 
all variables of clinical importance and all with univariate 
P<0.25. A backward elimination approach was used to 
find the best model. P<0.05 were considered statistically 
significant
  
3. Results
3.1. Study population
  During the study period, 1668 TB patients registered 
for treatment at the study sites. About 64% (1065) were 40 
years old or less and 963 (57.7%) were male. Also, 1 180 
(70.7%) resided in a rural area, and 1 390 (83.3%) of them 
received care at the rural facility (Table 1). Overall, the 
treatment default rate was 157 (9.4%), whilst 165 (9.9%) of 
the patients died. Patients who defaulted had a mean (SD) 
age of 41.4 (16.1) years while non-defaulters had a mean 
age of 38.2 (14.6 years); P=0.02. Also, patients who died 
during treatment had a mean (SD) age of 41.3 (14.8) compared 
to a mean of 38.2 (14.7) years among those who survived;
P=0.003. Of the 157 patients who defaulted; 134 (85.4%) had 
pulmonary tuberculosis, 100 (63.7%) were rural resident, 91 
(58%) were male, 97 (61.8%) received the longer treatment 
(2RHZE/6EH) regimen, 123 (78.3%) were HIV-infected, and 
115 (73.2%) received care in the private facility. Also, of the 
165 patients who died during treatment, 100 (60.6%) were 
male, 129 (78.2%) were rural residents, 94 (57%) received the 
longer anti-TB (2RHZE/6EH) regimen, 150 (90.9%) registered 
as new patients, 100 (60.6%) were HIV-negative, and 122 
(73.9%) received care at the private facility.         
Table 1
Demographic and clinical profile of 1668 TB patients, Nigeria, 2011 
- 2012.
Variables n (%)
Age (years)      ≤40 1 065 (63.8)
     >40    603 (36.2)
Gender      Female    705 (42.3)
     Male    963 (57.7)
Residence      Rural 1 180 (70.7)
     Urban    488 (29.3)
Facility      Private 1 390 (83.3)
     Public    278 (16.7)
Treatment category      New 1 552 (93.0)
     Retreatment    116 (7.0)
Type of TB      Smear-positive PTB    986 (59.1)
     Smear-negative PTB    588 (35.3)
     Extrapulmonary TB      94 (5.6)
Treatment Regimen      Regimen 1    879 (52.7)
     Regimen 2    789 (47.3)
HIV status      HIV - positive 1 326 (79.5)
     HIV - negative    342 (20.5)
ART given (n = 342)      Yes    117 (34,2)
     No    225 (65.8)
CPT given (n = 342)      Yes    189 (55.3)
     No    153 (44.7)
Regimen 1=8-months regimen; Regimen 2=6-month regimen; 
TB=tuberculosis; PTB=pulmonary tuberculosis; HIV=human 
immunodeficiency virus; ART=antiretroviral therapy; CPT= 
cotrimoxazole preventive therapy.
3.2. Duration of treatment before default and death
  The rate of treatment default for patients receiving both 6 
and 8-month regimes was high during the early months of 
treatment and generally decreased each consecutive month 
(Figure 1). Of 157 patients who defaulted during treatment, 
16 (10.2%) and 40 (25.5%) abandoned treatment during 
the first and second months respectively, thus 35.7% (56) 
defaulted during the intensive phase.  Of the 60 patients on 
the 6-month regimen, 27 (45%) defaulted within the first two 
months of treatment higher than the 29.9% (29/97) of patients 
on the 8-month regimen; P=0.05 (Figure 1). Also, of the 
165 patients who died during treatment, 109 (66.1%) and 42 
(25.4%) died during the first and second months respectively, 
thus 151 (91.5%) died during the intensive phase. Of 71 cases 
on the 6-month regimen, 93.0% (66) died during the first two 
months of treatment comparable to 90.4% (85/94) of patients 
on the 8-month regimen; P=0.6 (Figure 2). 
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Figure 1. Proportion of defaulters by time of default (months) for both 
six (n = 60) and eight-month (n = 97) regimens in Nigeria, 2011-
2012.
3.3. Univariate analyses of factors associated with treatment 
default and death among TB patients 
  Univariate analyses showed that residence, facility where 
care was given, type of TB and treatment regimen were 
significantly associated with treatment default (Table 2). 
Treatment default rates were higher among urban residents 
compared with rural residents (11.7% vs. 8.5%; P=0.04); 
patients treated at the tertiary (public) hospital had higher 
rates of treatment default compared with patients managed 
at the private (mission) hospital (15.1% vs. 8.3%; P< 0.001). 
Also, default rates were higher among patients with 
extrapulmonary TB compared with pulmonary TB (25.3% vs. 
8.3%; P<0.001); and patients treated using the longer anti-
TB regimen had higher rates of treatment default compared 
with patients treated with the shorter regimen (11% vs. 7.6%; 
P=0.02). Death rates were significantly associated with rural 
residence (P=0.03), care at the public facility (P<0.001), 
smear-negative TB/extrapulmonary TB (P<0.001), and HIV-
positive status (P<0.001) in univariate analysis (Table 3).
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Figure 2. Proportion of death by time of death (months) for both six (n 
= 71) and eight-month (n = 94) regimens in Nigeria, 2011-2012.
Table 2
Univariate analysis of factors associated with TB treatment default in Nigeria, 2011-2012.
Variables
Default (n=157) No default (n=15 11)
P-value 
[n (%)] [n (%)]
Age (years)      ≤40   94 (8.8)    971 (91.2) 0.300
     >40 63 (10.4)    540 (89.6)
Gender      Female   66 (9.4)    639 (90.6) 0.900
     Male   91 (9.4)    872 (90.6)
Residence      Rural 100 (8.5) 1 080 (91.5) 0.040
     Urban     57 (11.7)   431 (88.3)
Facility      Private 115 (8.3) 1275 (91.7) <0.001
     Public     42 (15.1)    236 (84.9)
Treatment category      New 149 (9.6) 1 403 (90.4) 0.300
     Retreatment     8 (6.9)    108 (93.1)
Type of TB      Smear-positive PTB   98 (9.9)    888 (90.1) <0.001
     Smear-negative PTB   34 (5.8)    554 (94.2)
     Extrapulmonary TB     25 (26.6)      69 (73.4)
Treatment regimen      Regimen 1     97 (11.0)    782 (89.0) 0.020
     Regimen 2   60 (7.6)    729 (92.4)
HIV status      HIV-negative 123 (9.3) 1 203 (90.7) 0.700
     HIV-positive   34 (9.9)    308 (90.1)
ART given (n =342)      Yes     15 (12.8)    102 (87.2) 0.200
     No   19 (8.4)    206 (91.6)
CPT given      Yes     20 (10.6)    169 (89.4) 0.700
     No   14 (9.2)    139 (90.8)
Regimen 1=8-months regimen; Regimen 2=6-month regimen; TB=tuberculosis; PTB=pulmonary tuberculosis; HIV=human immunodeficiency 
virus; ART=antiretroviral therapy; CPT=cotrimoxazole preventive therapy. 
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3.4. Risk factors of treatment default and death among TB 
patients
  The crude and adjusted ORs of treatment default 
determined by multivariable logistic regression analysis are 
shown in Table 4. The risk of default was higher in older 
patients [adjusted odds ratio (aOR) 1.2; 95% confidence 
interval (CI) 1.1 - 1.9)], smear-negative TB cases (aOR 2.3; 
CI 1.5 - 3.6), extrapulmonary TB cases (aOR 2.7; CI 1.3 - 
5.2), and patients who received the longer treatment regimen 
(aOR 1.6; CI 1.1 - 2.2). Female gender, urban residence, 
patient classification, hospital where care was received, and 
HIV status and care did not predict treatment default. Also, 
in a multivariable logistic regression model (Table 4), having 
extrapulmonary TB was a strong predictor of death during 
treatment (aOR 3.0; CI 1.4 - 6.1), as was rural residence (aOR 
1.7; CI 1.2 - 2.6), smear-negative TB (aOR 2.4; CI 1.7 - 3.5), 
HIV co-infection (aOR 2.5; CI 1.7 - 3.6), not receiving ART 
among HIV-infected TB patients (aOR 1.6; CI 1.1 - 2.9), and 
not receiving CPT among HIV-infected TB patients (aOR 1.7; 
CI 1.2 - 2.6).
4. Discussion
  Reducing TB-related loss to follow-up and mortality 
during treatment in TB control programmes in low-resource, 
high-incidence settings that have fully implemented the 
DOTS strategy may require targeted interventions tailored 
to local needs[12]. In this study, we aimed to determine 
subpopulations of TB patients at risk for mortality or default 
in two large health facilities in Nigeria. We found that   9.4% 
of the patients treated for TB at the study sites defaulted 
from treatment and 9.9% died during treatment.  The study 
showed treatment default to be associated with older age, 
smear-negative TB, extrapulmonary TB and receiving 
the 8-month antituberculosis regimen; and death to be 
associated with extrapulmonary TB, smear-negative TB, 
rural residence, HIV co-infection, not receiving ART, or CPT 
among TB/HIV patients.
  More than one third of the patients who defaulted 
abandoned treatment too early after treatment was started. 
Thus, a substantial number of patients who had sputum 
smear-positive pulmonary TB may still have had positive 
smears at the time they discontinued treatment[12]. Early 
abandonment of treatment may lead to poor treatment 
outcomes ie. treatment failure, death and the emergence of 
drug resistant TB. In contrast to previous studies in Kenya, 
Uzbekistan and Nigeria[6,12,16], most patients in this study 
defaulted during the continuation phase of treatment. Our 
finding agrees with recent studies in Morocco, Moldova, 
Indonesia and a systematic review which suggested that 
Table 3
Univariate analysis of factors associated with death during TB treatment, Nigeria, 2011-2012.
Variables Died (n = 165) [n (%)] Survived (n = 1 503) [n (%)] P-value 
Age (years)      ≤40   95 (8.9)   970 (91.1) 0.08
     >40     70 (11.6)   533 (88.4)
Gender      Female   65 (9.2)   640 (90.8) 0.43
     Male   100 (10.4)   863 (89.6)
Residence      Rural   129 (10.9) 1 051 (89.1) 0.03
     Urban   36 (7.4)   452 (92.6)
Facility      Private 122 (8.8) 1 268 (91.2) <0.001
     Public     43 (15.5)   235 (84.5)
Treatment category      New 150 (9.7) 1 402 (90.3) 0.3
     Retreatment     15 (12.9)    101 (87.1)
Type of TB      Smear-positive PTB   56 (5.7)    930 (94.3) <0.001
     Smear-negative PTB     94 (16.0)    494 (84.0)
     Extrapulmonary TB     15 (16.0)     79 (84.0)
Treatment regimen      Regimen 1     94 (10.7)    785 (89.3) 0.3
     Regimen 2   71 (9.0)    718 (91.0)
HIV status      HIV-negative 100 (7.5) 1 226 (92.5) <0.001
     HIV-positive     65 (19.0)    277 (81.0)
ART given (n = 342)      Yes     17 (14.5)    100 (85.5) 0.1
     No     48 (21.3)    177 (78.7)
CPT given      Yes     31 (16.4)    158 (83.6) 0.2
     No     34 (22.2)    119 (77.8)
Regimen 1=8-months regimen; Regimen 2=6-month regimen; TB=tuberculosis; PTB=pulmonary tuberculosis; HIV=human immunodeficiency 
virus; ART=antiretroviral therapy; CPT=cotrimoxazole preventive therapy.
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most patients tend to default during the continuation phase 
of treatment in low-and middle-income countries[9-11,21]. 
Higher default rates during the continuation phase of 
treatment have been suggested to be due to ongoing direct 
and indirect costs of care and symptom resolution[10,11,21]. 
More intensive patient education especially during the 
second to the fourth month of treatment and possibly 
economic support are needed to reduce treatment default
  The risk of default and death increased in patients with 
smear-negative TB and extrapulmonary TB. These clinical 
factors have been associated with death in several studies[13-
19]. This may be due to increased co-morbidities associated 
with smear-negative TB and extrapulmonary TB. It may also 
be that some of these cases had other diseases and were 
misdiagnosed and treated for TB resulting in poor outcomes. 
However, these have been reduced through the use of 
standardised algorithms in making a diagnosis of smear-
negative TB; and histology for extrapulmonary TB[22,23]. 
Use of molecular diagnostics techniques (for example 
Gene Xpert MTB/RIF) may enhance early and appropriate 
diagnosis of smear-negative and extrapulmonary TB in 
low-income settings and should be scaled-up in these 
settings. The reason why patients with smear-negative 
and extrapulmonary TB patients had higher default rates is 
not clear.  Thus, special care for such patients is therefore 
necessary for a successful control programme.
  We found that older age was associated with an increased 
risk of default. This observation has been suggested to be 
due to increasing co-morbidities and general physical 
disability associated with old age[27]. Older age has been 
shown to increase default rates in other settings. In China, 
older patients were more likely to default than younger ones; 
and in northeastern Thailand, default rates were higher in 
older individuals[27,28]. Also, our finding on the protective 
effect of the shorter anti-tuberculosis regimen against 
default is reassuring and have confirmed previously held 
belief that shorter treatment regimen could reduce default 
rates[21]. Interventions to lower default rates in low-income 
settings are likely to include special care for older patients 
and sustained use of shorter treatment regimen.
  Patients residing in a rural area had a higher risk of 
death. The health system in high burden countries into 
which TB control is fully integrated suffers from lack of 
human resources and limited outreach services for the 
Table 4
Multivariable logistic regression analysis of factors associated with treatment default and death among TB patients, Nigeria, 2011-2012.
Variables Crude OR (95% CI) Adjusted OR (95% CI) Adjusted P-value
Treatment default Older age (years) 1.2 (0.9 - 1.7) 1.2 (1.1 - 1.9) 0.004
Female gender 1.0 (0.7 - 1.4) 1.0 (0.8 - 1.5) 0.650
Urban residence 1.4 (1.0 - 2.0) 1.3 (0.9 - 1.8) 0.200
New TB case 1.4 (0.7 - 3.0) 1.2 (0.6 - 2.6) 0.600
Care at public facility 2.0 (1.4 - 2.9) 1.2 (0.7 - 2.1) 0.500
Smear-negative PTB case 2.1 (1.4 - 3.1) 2.3 (1.5 - 3.6) <0.001
Extrapulmonary TB case 3.9 (2.4 - 6.5) 2.7 (1.3 - 5.2) 0.005
HIV-positive status 1.1 (0.7 - 1.6) 1.4 (0.9 - 2.2) 0.500
ART given 1.6 (0.8 - 3.3) 1.5 (0.9 - 3.5) 0.090
CPT given 1.2 (0.6 - 2.4) 1.1 (0.7 - 2.5) 0.600
Regimen 1 1.5 (1.1 - 2.1) 1.6 (1.1 - 2.2) 0.010
Death Older age (years) 1.3 (1.0 - 1.9) 1.0 (0.9 - 1.1) 0.110
Male gender 1.1 (0.8 - 1.6) 1.3 (0.9 - 1.8) 0.160
Rural residence 1.5 (1.1 - 2.3) 1.7 (1.2 - 2.6) 0.008
Retreatment TB case 1.4 (0.8 - 2.5) 1.3 (0.7 - 2.4) 0.330
Care at public facility 1.9 (1.3 - 2.8) 1.4 (0.9 - 2.2) 0.200
Smear-negative PTB case 2.7 (2.0 - 3.8) 2.4 (1.7 - 3.5) <0.001
Extrapulmonary TB case 1.8 (1.0 - 3.2) 2.9 (1.4 - 6.1) 0.005
HIV-positive status 2.9 (2.1 - 4.1) 2.5 (1.7 - 3.6) <0.001
No ART given 1.5 (0.9 - 2.5) 1.6 (1.1 - 2.9) 0.010
No CPT given 1.5 (0.9 - 2.7) 1.7 (1.2 - 2.6) 0.007
Regimen 1 1.2 (0.9 - 1.7) 1.2 (0.9 - 1.7) 0.260
Regimen 1=8-months regimen; Regimen 2=6-month regimen; TB=tuberculosis; PTB=pulmonary tuberculosis; HIV= human immunodeficiency 
virus; ART=antiretroviral therapy; CPT=cotrimoxazole preventive therapy. 
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rural population - this is particularly seen in rural areas of 
Ethiopia, Indonesia, Pakistan and Nigeria[6]. Also, the poorer 
socioeconomic status of rural residents may constitute a 
hindrance in their ability to access health services[8,29,30]. 
The reasons why rural residents TB patients had higher risk 
of death needs to be evaluated in further studies.
  Consistent with previous studies[17-20], HIV co-infection 
increased the risk of death. However, these deaths may be 
due to other opportunistic infections as have been shown by 
postmortem studies[20,31]. In individuals with early stages of 
HIV, the effects of TB co-infection are most detrimental as 
they have accelerated decline in immune function resulting 
in high all-cause mortality even after the completion of 
anti-tuberculosis treatment[20]. Cotrimoxazole prophylaxis 
and antiretroviral therapy use are two very important 
interventions to reduce mortality in HIV-infected TB 
patients[32,33]. Although the medium to long term benefits of 
cotrimoxazole preventive therapy and antiretroviral therapy 
have been demonstrated in TB/HIV patients, data so far show 
that none of these interventions significantly decrease death 
in the early months of anti-tuberculosis treatment[20,34]. 
In our study, more than 90% of TB/HIV deaths in patients 
who received either the shorter or longer anti-TB regimen 
occurred within the first two months of treatment. Therefore, 
identifying the clinical and biochemical determinants of 
death in the first two months of treatment among HIV-
infected TB patients in high-burden countries is crucial 
for a successful control programme and needs to be further 
explored. 
  Although this study provides important information for 
the improvement of TB treatment outcome in Nigeria, our 
analysis is limited by the use of retrospective data available 
from TB registers. The registers used did not contain 
information on patient income, employment status, alcohol 
consumption, tobacco use, malnutrition, co-morbidities, 
patients’ knowledge of TB, distance to health facility, and 
patients’ perception of TB services. For HIV-infected 
patients, there were no information on combination of drugs 
received and CD4 count. These factors have been found to 
predict default and/or death in other settings[7-20,28]. Future 
quantitative and qualitative studies on how and why default 
occurs and what interventions may be most effective may 
improve upon these limitations.
  We conclude that treatment default and death remains a 
barrier to successful TB control in Nigeria; and it is driven 
by many remediable factors. Interventions that provide 
special care for older patients and patients with smear-
negative and extrapulmonary TB patients may help to reduce 
default rates in this and similar settings. Furthermore, 
patients with smear-negative TB and extrapulmonary 
TB, rural residents, HIV co-infection require special 
attention to reduce mortality in this and similar settings; 
and collaborative TB/HIV activities including the use of 
cotrimoxazole prophylaxis needs to be scaled-up among TB/
HIV co-infected individuals to improve treatment outcomes. 
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